Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J Silver

Showing results (101-110 of 108) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 108 results.
Science (New York, N.Y.)|April 7, 1978
Prostacyclin: a potentially valuable agent for preserving myocardial tissue in acute myocardial ischemiaA M Lefer, M L Ogletree, J B Smith, et al.
Thrombosis and Haemostasis|April 30, 1981
Plasma and platelet lipid composition and platelet aggregation by arachidonic acid in women on the pillB Sadurska, M T Tacconi, G di Minno, et al.
Arteriosclerosis and Thrombosis : a Journal of Vascular Biology|July 1, 1991
A role for platelets and thrombin in the juvenile stroke of two siblings with defective thrombin-adsorbing capacity of fibrin(ogen)G Di Minno, J Martinez, F Cirillo, et al.
Lancet (London, England)|May 14, 1977
Rapid and easy preparation of prostacyclinK C Nicolaou, W E Bernette, B P Gasic, et al.
Circulation|August 1, 1995
Adjunctive selectin blockade successfully reduces infarct size beyond thrombolysis in the electrolytic canine coronary artery modelM J Silver, J M Sutton, S Hook, et al.
Journal of the American College of Cardiology|February 14, 1998
Influence of a randomized clinical trial on practice by participating investigators: lessons from the Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT). CAVEAT I and II InvestigatorsN A Omoigui, M J Silver, L A Rybicki, et al.
Stroke|October 6, 2001
Initial experience of platelet glycoprotein IIb/IIIa inhibition with abciximab during carotid stenting: a safe and effective adjunctive therapyS R Kapadia, C T Bajzer, K M Ziada, et al.
The American Journal of Cardiology|October 6, 2000
Safety of femoral closure devices after percutaneous coronary interventions in the era of glycoprotein IIb/IIIa platelet blockadeF A Cura, S R Kapadia, P L L'Allier, et al.
Pageof 11

Showing results (101-110 of 108) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 108 results.
Science (New York, N.Y.)|April 7, 1978
Prostacyclin: a potentially valuable agent for preserving myocardial tissue in acute myocardial ischemiaA M Lefer, M L Ogletree, J B Smith, et al.
Thrombosis and Haemostasis|April 30, 1981
Plasma and platelet lipid composition and platelet aggregation by arachidonic acid in women on the pillB Sadurska, M T Tacconi, G di Minno, et al.
Arteriosclerosis and Thrombosis : a Journal of Vascular Biology|July 1, 1991
A role for platelets and thrombin in the juvenile stroke of two siblings with defective thrombin-adsorbing capacity of fibrin(ogen)G Di Minno, J Martinez, F Cirillo, et al.
Lancet (London, England)|May 14, 1977
Rapid and easy preparation of prostacyclinK C Nicolaou, W E Bernette, B P Gasic, et al.
Circulation|August 1, 1995
Adjunctive selectin blockade successfully reduces infarct size beyond thrombolysis in the electrolytic canine coronary artery modelM J Silver, J M Sutton, S Hook, et al.
Journal of the American College of Cardiology|February 14, 1998
Influence of a randomized clinical trial on practice by participating investigators: lessons from the Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT). CAVEAT I and II InvestigatorsN A Omoigui, M J Silver, L A Rybicki, et al.
Stroke|October 6, 2001
Initial experience of platelet glycoprotein IIb/IIIa inhibition with abciximab during carotid stenting: a safe and effective adjunctive therapyS R Kapadia, C T Bajzer, K M Ziada, et al.
The American Journal of Cardiology|October 6, 2000
Safety of femoral closure devices after percutaneous coronary interventions in the era of glycoprotein IIb/IIIa platelet blockadeF A Cura, S R Kapadia, P L L'Allier, et al.
Pageof 11